Cholinergic control of inflammation

. Cytokine production is necessary to protect against pathogens and promote tissue repair, but excessive cytokine release can lead to systemic inflammation, organ failure and death. Inflammatory responses are finely regulated to effectively guard from noxious stimuli. The central nervous system inte...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of internal medicine 2009-06, Vol.265 (6), p.663-679
Hauptverfasser: Rosas‐Ballina, M., Tracey, K. J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 679
container_issue 6
container_start_page 663
container_title Journal of internal medicine
container_volume 265
creator Rosas‐Ballina, M.
Tracey, K. J.
description . Cytokine production is necessary to protect against pathogens and promote tissue repair, but excessive cytokine release can lead to systemic inflammation, organ failure and death. Inflammatory responses are finely regulated to effectively guard from noxious stimuli. The central nervous system interacts dynamically with the immune system to modulate inflammation through humoral and neural pathways. The effect of glucocorticoids and other humoral mediators on inflammatory responses has been studied extensively in the past decades. In contrast, neural control of inflammation has only been recently described. We summarize autonomic regulation of local and systemic inflammation through the ‘cholinergic anti‐inflammatory pathway’, a mechanism consisting of the vagus nerve and its major neurotransmitter, acetylcholine, a process dependent on the nicotinic acetylcholine receptor α7 subunit. We recapitulate additional sources of acetylcholine and their contribution to the inflammatory response, as well as acetylcholine regulation by acetylcholinesterase as a means to attenuate inflammation. We discuss potential therapeutic applications to treat diseases characterized by acute or chronic inflammation, including autoimmune diseases, and propose future research directions.
doi_str_mv 10.1111/j.1365-2796.2009.02098.x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4540232</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67323775</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5698-69aa6405a822cff984e97c8863b4d79ad035c3f0203f9bbde3085bcd5b0c1ee53</originalsourceid><addsrcrecordid>eNqNkMtOwzAQRS0EgvL4BVQJwS5hbMeOvUFCFU-B2MDachy7uHJiiFsef09CqwI7vPFIc-fOnYPQGEOO-3c6yzHlLCOl5DkBkDkQkCL_2ECjdWMTjUCyIuOCwA7aTWkGgClw2EY7WBZyKEfoaPIcg29tN_VmbGI772IYRzf2rQu6afTcx3YfbTkdkj1Y_Xvo6fLicXKd3T1c3UzO7zLDuBQZl1rzApgWhBjnpCisLI0QnFZFXUpdA2WGuj4qdbKqaktBsMrUrAKDrWV0D50tfV8WVWNrY_s0OqiXzje6-1RRe_W30_pnNY1vqmAFEEp6g5OVQRdfFzbNVeOTsSHo1sZFUrzsRWU5bBJLoeliSp116yUY1EBYzdQAUg0g1UBYfRNWH_3o4e-QP4MrpL3geCXQyejgOt0an9Y6gguKBfl17bsP9vPfAdTtw839UNIvxO6XjA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67323775</pqid></control><display><type>article</type><title>Cholinergic control of inflammation</title><source>MEDLINE</source><source>IngentaConnect Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Online Library Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Rosas‐Ballina, M. ; Tracey, K. J.</creator><creatorcontrib>Rosas‐Ballina, M. ; Tracey, K. J.</creatorcontrib><description>. Cytokine production is necessary to protect against pathogens and promote tissue repair, but excessive cytokine release can lead to systemic inflammation, organ failure and death. Inflammatory responses are finely regulated to effectively guard from noxious stimuli. The central nervous system interacts dynamically with the immune system to modulate inflammation through humoral and neural pathways. The effect of glucocorticoids and other humoral mediators on inflammatory responses has been studied extensively in the past decades. In contrast, neural control of inflammation has only been recently described. We summarize autonomic regulation of local and systemic inflammation through the ‘cholinergic anti‐inflammatory pathway’, a mechanism consisting of the vagus nerve and its major neurotransmitter, acetylcholine, a process dependent on the nicotinic acetylcholine receptor α7 subunit. We recapitulate additional sources of acetylcholine and their contribution to the inflammatory response, as well as acetylcholine regulation by acetylcholinesterase as a means to attenuate inflammation. We discuss potential therapeutic applications to treat diseases characterized by acute or chronic inflammation, including autoimmune diseases, and propose future research directions.</description><identifier>ISSN: 0954-6820</identifier><identifier>EISSN: 1365-2796</identifier><identifier>DOI: 10.1111/j.1365-2796.2009.02098.x</identifier><identifier>PMID: 19493060</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Acetylcholine - immunology ; alpha7 ; Animals ; Biological and medical sciences ; Brain - metabolism ; cholinergic ; Cholinergic Agents - immunology ; General aspects ; inflammation ; Inflammation - immunology ; innate immunity ; Medical sciences ; Mice ; Mice, Knockout ; Neural Pathways - metabolism ; Receptors, Cholinergic - immunology ; Receptors, Cholinergic - metabolism ; Receptors, Nicotinic - metabolism ; Sepsis - immunology ; Tumor Necrosis Factor-alpha - metabolism ; Vagus Nerve - immunology ; Vagus Nerve - physiology</subject><ispartof>Journal of internal medicine, 2009-06, Vol.265 (6), p.663-679</ispartof><rights>2009 Blackwell Publishing Ltd</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5698-69aa6405a822cff984e97c8863b4d79ad035c3f0203f9bbde3085bcd5b0c1ee53</citedby><cites>FETCH-LOGICAL-c5698-69aa6405a822cff984e97c8863b4d79ad035c3f0203f9bbde3085bcd5b0c1ee53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2796.2009.02098.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2796.2009.02098.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,309,310,314,776,780,785,786,881,1411,1427,23909,23910,25118,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21431825$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19493060$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rosas‐Ballina, M.</creatorcontrib><creatorcontrib>Tracey, K. J.</creatorcontrib><title>Cholinergic control of inflammation</title><title>Journal of internal medicine</title><addtitle>J Intern Med</addtitle><description>. Cytokine production is necessary to protect against pathogens and promote tissue repair, but excessive cytokine release can lead to systemic inflammation, organ failure and death. Inflammatory responses are finely regulated to effectively guard from noxious stimuli. The central nervous system interacts dynamically with the immune system to modulate inflammation through humoral and neural pathways. The effect of glucocorticoids and other humoral mediators on inflammatory responses has been studied extensively in the past decades. In contrast, neural control of inflammation has only been recently described. We summarize autonomic regulation of local and systemic inflammation through the ‘cholinergic anti‐inflammatory pathway’, a mechanism consisting of the vagus nerve and its major neurotransmitter, acetylcholine, a process dependent on the nicotinic acetylcholine receptor α7 subunit. We recapitulate additional sources of acetylcholine and their contribution to the inflammatory response, as well as acetylcholine regulation by acetylcholinesterase as a means to attenuate inflammation. We discuss potential therapeutic applications to treat diseases characterized by acute or chronic inflammation, including autoimmune diseases, and propose future research directions.</description><subject>Acetylcholine - immunology</subject><subject>alpha7</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Brain - metabolism</subject><subject>cholinergic</subject><subject>Cholinergic Agents - immunology</subject><subject>General aspects</subject><subject>inflammation</subject><subject>Inflammation - immunology</subject><subject>innate immunity</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Neural Pathways - metabolism</subject><subject>Receptors, Cholinergic - immunology</subject><subject>Receptors, Cholinergic - metabolism</subject><subject>Receptors, Nicotinic - metabolism</subject><subject>Sepsis - immunology</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><subject>Vagus Nerve - immunology</subject><subject>Vagus Nerve - physiology</subject><issn>0954-6820</issn><issn>1365-2796</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkMtOwzAQRS0EgvL4BVQJwS5hbMeOvUFCFU-B2MDachy7uHJiiFsef09CqwI7vPFIc-fOnYPQGEOO-3c6yzHlLCOl5DkBkDkQkCL_2ECjdWMTjUCyIuOCwA7aTWkGgClw2EY7WBZyKEfoaPIcg29tN_VmbGI772IYRzf2rQu6afTcx3YfbTkdkj1Y_Xvo6fLicXKd3T1c3UzO7zLDuBQZl1rzApgWhBjnpCisLI0QnFZFXUpdA2WGuj4qdbKqaktBsMrUrAKDrWV0D50tfV8WVWNrY_s0OqiXzje6-1RRe_W30_pnNY1vqmAFEEp6g5OVQRdfFzbNVeOTsSHo1sZFUrzsRWU5bBJLoeliSp116yUY1EBYzdQAUg0g1UBYfRNWH_3o4e-QP4MrpL3geCXQyejgOt0an9Y6gguKBfl17bsP9vPfAdTtw839UNIvxO6XjA</recordid><startdate>200906</startdate><enddate>200906</enddate><creator>Rosas‐Ballina, M.</creator><creator>Tracey, K. J.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200906</creationdate><title>Cholinergic control of inflammation</title><author>Rosas‐Ballina, M. ; Tracey, K. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5698-69aa6405a822cff984e97c8863b4d79ad035c3f0203f9bbde3085bcd5b0c1ee53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Acetylcholine - immunology</topic><topic>alpha7</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Brain - metabolism</topic><topic>cholinergic</topic><topic>Cholinergic Agents - immunology</topic><topic>General aspects</topic><topic>inflammation</topic><topic>Inflammation - immunology</topic><topic>innate immunity</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Neural Pathways - metabolism</topic><topic>Receptors, Cholinergic - immunology</topic><topic>Receptors, Cholinergic - metabolism</topic><topic>Receptors, Nicotinic - metabolism</topic><topic>Sepsis - immunology</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><topic>Vagus Nerve - immunology</topic><topic>Vagus Nerve - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rosas‐Ballina, M.</creatorcontrib><creatorcontrib>Tracey, K. J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of internal medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rosas‐Ballina, M.</au><au>Tracey, K. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cholinergic control of inflammation</atitle><jtitle>Journal of internal medicine</jtitle><addtitle>J Intern Med</addtitle><date>2009-06</date><risdate>2009</risdate><volume>265</volume><issue>6</issue><spage>663</spage><epage>679</epage><pages>663-679</pages><issn>0954-6820</issn><eissn>1365-2796</eissn><abstract>. Cytokine production is necessary to protect against pathogens and promote tissue repair, but excessive cytokine release can lead to systemic inflammation, organ failure and death. Inflammatory responses are finely regulated to effectively guard from noxious stimuli. The central nervous system interacts dynamically with the immune system to modulate inflammation through humoral and neural pathways. The effect of glucocorticoids and other humoral mediators on inflammatory responses has been studied extensively in the past decades. In contrast, neural control of inflammation has only been recently described. We summarize autonomic regulation of local and systemic inflammation through the ‘cholinergic anti‐inflammatory pathway’, a mechanism consisting of the vagus nerve and its major neurotransmitter, acetylcholine, a process dependent on the nicotinic acetylcholine receptor α7 subunit. We recapitulate additional sources of acetylcholine and their contribution to the inflammatory response, as well as acetylcholine regulation by acetylcholinesterase as a means to attenuate inflammation. We discuss potential therapeutic applications to treat diseases characterized by acute or chronic inflammation, including autoimmune diseases, and propose future research directions.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>19493060</pmid><doi>10.1111/j.1365-2796.2009.02098.x</doi><tpages>17</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0954-6820
ispartof Journal of internal medicine, 2009-06, Vol.265 (6), p.663-679
issn 0954-6820
1365-2796
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4540232
source MEDLINE; IngentaConnect Open Access Journals; Wiley Online Library Journals Frontfile Complete; Wiley Online Library Free Content; EZB-FREE-00999 freely available EZB journals
subjects Acetylcholine - immunology
alpha7
Animals
Biological and medical sciences
Brain - metabolism
cholinergic
Cholinergic Agents - immunology
General aspects
inflammation
Inflammation - immunology
innate immunity
Medical sciences
Mice
Mice, Knockout
Neural Pathways - metabolism
Receptors, Cholinergic - immunology
Receptors, Cholinergic - metabolism
Receptors, Nicotinic - metabolism
Sepsis - immunology
Tumor Necrosis Factor-alpha - metabolism
Vagus Nerve - immunology
Vagus Nerve - physiology
title Cholinergic control of inflammation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T00%3A02%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cholinergic%20control%20of%20inflammation&rft.jtitle=Journal%20of%20internal%20medicine&rft.au=Rosas%E2%80%90Ballina,%20M.&rft.date=2009-06&rft.volume=265&rft.issue=6&rft.spage=663&rft.epage=679&rft.pages=663-679&rft.issn=0954-6820&rft.eissn=1365-2796&rft_id=info:doi/10.1111/j.1365-2796.2009.02098.x&rft_dat=%3Cproquest_pubme%3E67323775%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67323775&rft_id=info:pmid/19493060&rfr_iscdi=true